Emmaus Life Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012 - 1999
Net Income	-10.69	-15.95	1.35	-54.84	-9.6	-7.11	-5.94	-3.38	-2.66	-10.91	Upgrade
Depreciation & Amortization	0.05	0.06	0.06	0.07	0.12	0.05	0.01	0.01	0.01	0.01	Upgrade
Share-Based Compensation	0.02	0.55	0.74	3.81	0	2.09	0.76	0.24	1.01	1.26	Upgrade
Other Operating Activities	5.54	14.08	-4.6	46.44	0.44	0.19	2.2	1.02	-1.63	6.6	Upgrade
Operating Cash Flow	-5.07	-1.25	-2.45	-4.52	-9.04	-4.79	-2.98	-2.11	-3.27	-3.04	Upgrade
Capital Expenditures	-0.03	-0.07	-26.18	-0.06	-0.06	-0.13	-0.08	0	0	0	Upgrade
Acquisitions	5.28	0	30.12	-1.65	-0.31	-0.19	0	0	0	0	Upgrade
Change in Investments	-8.2	-6.3	-65.72	1.42	-	-0.38	-	-	-	-	Upgrade
Other Investing Activities	0.56	-	67.25	-1.2	-	0.22	-	0	-	0	Upgrade
Investing Cash Flow	-2.39	-6.38	5.47	-1.48	-0.36	-0.48	-0.08	0	0	0	Upgrade
Common Stock Issued	0	0	0.14	8.59	0.93	10.46	0	0	1.69	2.96	Upgrade
Other Financing Activities	7.23	7.41	-2.45	-4.71	6.28	-0.06	2.95	1.35	1.64	1.36	Upgrade
Financing Cash Flow	7.23	7.41	-2.31	3.88	7.21	10.4	2.95	1.35	3.33	4.32	Upgrade
Net Cash Flow	-0.26	-0.21	0.72	-2.14	-2.19	5.13	-0.11	-0.81	-0.03	1.27	Upgrade
Free Cash Flow	-5.1	-1.33	-28.63	-4.58	-9.09	-4.92	-3.06	-2.11	-3.27	-3.04	Upgrade
Free Cash Flow Margin	-27.73%	-6.44%	-123.56%	-20.14%	-691.29%	-3830.43%	-3596.59%	-2112.69%	-2421.24%	-2319.48%	Upgrade
Free Cash Flow Per Share	-0.10	-0.03	-0.59	-0.11	-10.49	-10.48	-28.61	-24.93	-39.52	-48.07	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.